AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Can-Fite BioPharma Ltd.

ILA 263.30 -$2736.70 (-91.22%)
TLV · 30 Oct 2026 11:44 UTC
Previous Close
ILA 262.90
Day Range
ILA 256.00ILA 264.10
Year Range
ILA 256.00ILA 3000.00
Market Cap
11.28M
AVG Volume
25.13K
Trailing/Forward PE
-0.24/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2027-04-01
Primary Exchange
Tel Aviv Stock ExchangeIL
Revenue (USD) · TTM
0200K400K600K800K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CANF.TA Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2405K
26 Q1405K
25 Q4405K
25 Q3482.5K
25 Q2560K
25 Q1617K
24 Q4674K
24 Q3650K
24 Q2667K
24 Q1705K
Net Income (USD) · TTM
-10M-7.5M-5M-2.5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CANF.TA Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-9.55M
26 Q1-9.69M
25 Q4-9.83M
25 Q3-9.31M
25 Q2-8.8M
25 Q1-8.34M
24 Q4-7.88M
24 Q3-7.57M
24 Q2-7.37M
24 Q1-7.06M
Operating Income (USD) · TTM
-10M-7.5M-5M-2.5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CANF.TA Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-9.73M
26 Q1-9.84M
25 Q4-9.95M
25 Q3-9.44M
25 Q2-8.93M
25 Q1-8.53M
24 Q4-8.13M
24 Q3-7.95M
24 Q2-7.79M
24 Q1-7.53M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: CANF.TA

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 1 Apr 2027.

Can-Fite BioPharma Ltd.
CANF.TA
Stockpicker

Video analysis: CANF.TA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CANF.TA

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.